{"id":"W4393931572","doi":"10.1183/13993003.01521-2023","title":"Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme","year":2024,"lang":"en","type":"article","venue":"European Respiratory Journal","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; McGill University; St. Joseph’s Healthcare Hamilton; AstraZeneca (Canada)","funders":"CSL Behring; AstraZeneca","keywords":"Medicine; Benralizumab; Exacerbation; Asthma; Internal medicine; Mepolizumab; Eosinophil","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007721504,0.0005860575,0.0005103144,0.0004912,0.0002917879,0.0006319775,0.0004595047,0.0005015688,0.001378267],"category_scores_gemma":[0.004356982,0.0003360565,0.00107665,0.0005792737,0.0003778381,0.0005037604,0.0008363784,0.0006632134,0.00027355],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006167393,"about_ca_system_score_gemma":0.0006800389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008428133,"about_ca_topic_score_gemma":0.001585702,"domain_scores_codex":[0.9955219,0.003293782,0.0002053271,0.0004546374,0.0003176877,0.0002066685],"domain_scores_gemma":[0.9939396,0.001696721,0.002674251,0.0007233205,0.000367552,0.000598506],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1045761,0.003168768,0.8465638,0.0004088819,0.002323308,0.0001171343,0.0003295103,0.001297486,0.002089897,0.0000821943,0.001426054,0.03761688],"study_design_scores_gemma":[0.01013578,0.01991484,0.963457,0.00008170251,0.0009979251,0.0004103747,0.000178955,0.001855042,0.0009073745,0.00008416332,0.001937903,0.00003901496],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976225,0.0006526704,0.0002187847,0.00007209732,0.000006984803,0.0002119315,0.0008971454,0.000009587212,0.0003082038],"genre_scores_gemma":[0.9967059,0.0001583565,0.0005729886,0.00006177289,0.00003006137,0.0002710007,0.002021227,0.000005377109,0.0001732724],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007721504,"threshold_uncertainty_score":0.04083568,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05849140917254506,"score_gpt":0.3310405535419136,"score_spread":0.2725491443693686,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}